Member Info for TrekMadone

Agree icemax and that’s where the short comes in to hedge the downside. Know idea what the delta is but now it’s pretty much done we can reach a more balanced market driven SP.

Trek

Whilst every share is a trading opportunity imo the money to be made here is from now, up to and possibly beyond 50p, to ahead of the 2023 finals.

We are not going to see the benefits of the air pathogen/radiation detector revs until then. That’s the biggie! We are looking at soak testing in H2. It then takes time for sales and scale. On the threat side apart from direct competition the obvious one is the air purification technology.

Not a plug, but I am invested in Directa Plus (DCTA) that are developing such tech. It has a 99.9% covid kill rate. But in reality the two systems should work hand in hand so new tech should be complimentary even the waste water analysis.

I think this rerate here is just starting. The market understands that momentum will pick up starting with those once parked contracts.

I have been through the financials here whilst I don’t envisage any raise at the moment I would not be surprised to see a raise for growth end of year/next year. Their cash tops from memory was £13m on the books but the delays have paired back cash to just over £5m. The revenue from contracts are front ended and they have capacity to upscale for now.

Any raise will be at a much much higher SP and be accretive.

I have been building a position here and will continue to do so sub 50p as funds become available with a 1-2yr view. It’s just my age. Others with a longer term objective will fair better assuming KMK are not bought!

Usual caveats.

Trek

I noticed how they marked this down as much as poss to try and grab some shares! Lol!

Buys came in and back to where we were in a flash!

Diamond hands!

Trek

Lol Carib/hub,

I’ve been on tour on Reddit. Had to learn the lingo to understand what has been going on in the world other than from our good old biased media.

All part of one’s wider DD. If there is an assault on the pension fund one has to understand the machinations and perhaps even use to one’s advantage.

Guess by the gobsmacked response I am now at last bi-lingo!

Lol!

Now for a beer!

Trek

Yep fat finger 82p UT at close. May be able to snap a bargain at 08:00 tomorrow!

https://api.londonstockexchange.com/api/gw/lse/download/DCTA/trades

Trek

Probably my post. Kiss of death!

Still don’t change the fundamentals, I am not expecting a placing.. Hopefully it’s just a seller cleared and we can have some liquidity here.

Trek

Good to see the liquidity here. Should enable BGF to reach their number soon.

Trek

They have used the sale to pay for the warrant conversion. To be fair they didn’t hang around noticing the market. They could have probably ticked the non uk issuer box and used 5 days.

My concern was the holdings getting back to +20%. Whilst I would rather they were out (that’s my personal view based on current Canberra/Beijing politics). I can live with 7.4% as that is even better than any arms length agreement.

CB is free to negotiate without any worry of to and fro with a cornerstone investor. Whilst it’s not significant it’s a bit like oiling the transmission before a long bike ride. The gears just run that much more smoothly......

“Director Appointment Rights and Pre-Emption Rights

Pursuant to completion of the subscription, Shenyang is able to recommend up to two directors to be appointed to the board of the Company. ECR will make further announcements in due course as and when any board appointments are made.

Shenyang will, from Admission, be granted certain pre-emption rights for so long as Shenyang holds more than 20% of the issued share capital of the Company.

Investor Relationship Agreement

The Company, Shenyang and its connected parties and Cairn Financial Advisers LLP have entered into a relationship agreement, pursuant to which Shenyang, in its capacity as a substantial shareholder of ECR, has given various undertakings to the Company to ensure that the relationship and any arrangements between Shenyang, its associates and ECR remain on an arm’s length basis and are transacted on normal commercial terms. The relationship agreement will remain in force for so long as Shenyang holds a direct or indirect interest in at least 20% of the Company's issued ordinary share capital.”

Trek

So looking at the TR1 they sold their shares and are holding the conversion, for now at least. I can live with 7.4%. No seat on the BoD for that.

Back to normal now.

Well done those that bought at 3p!

Trek

Well timed buy!

I have whizzed through search engines and only this recently... nothing on court yet.

https://www.naija247news.com/2021/01/28/savannah-energy-issues-2021-guidance-reduces-cost-estimates-by-13/#.YBK9n8qnyhA

Trek

Always wondered what justified the 6 fig salary. Once I played darts with one who couldn’t work out what double we needed! Not that it mattered! Lol!

Trek

It’s recovered from the NexTech spike and subsequent sell off. Been little volume but enough opportunity over the last month for people to leave if they so wished.

I am hoping we have seen the back of 88/92/88/92 incessant prices and we sneak quietly through £1 soon.

Trek

It’s pretty impressive to achieve that without use of agents but (and I am invested) it’s not the money shot. It’s further validation. Putting foundations strongly under 10p for now will do. Especially in this brutal market! There’s more to come. When it’s fully peer reviewed that’s when the rerate for gad will arrive.

Usual caveats

Trek

It could be along the lines of ‘Newmont’ spending say £2m for a 30% earn in over 12 months. £4m spend for 60% earn in over 2 years. In that time ECR need to spend £1m and £2m in two years and prove x no of Oz’s. If at total of x Oz’s JORC after 2 years. ECR get a 40% free carry or else have to spend £1m for a 30% carry if x resources JORC.

All the figures are illustrative.

E.g. ECR could go a route to settle for less say 80/20 free and less spend.

Or they could sell the lot or have an in exchange for a net smelting royalty like Argentina ( from memory)

So there are lots of variations on the above.

Trek

Hi djia,

A reasonable assessment on the charts. I likewise expected 4p to offer up more resistance and bought another lot on that basis for my trading pot. So I also got it wrong! Else I would have sold and bought back at 3p to collect more shares.

Why didn’t I sell? Well as I like to think I understand the reason for the drop and the opportunity that I missed I now expect it to catapult back up again. Ergo I’m fine with looking at a 30% paper loss. I am just so frustrated at not being able to buy more at these levels as fully invested elsewhere waiting news so it’s now like missing two opportunities!

Trek

And for those laterally minded here is a read across from Microsoft’s results yesterday and how cloud is transforming income.....

“Microsoft said Azure revenue grew 50%. Analysts had expected around 42% growth. Microsoft doesn’t disclose Azure revenue in dollars.

The More Personal Computing segment, containing Windows, gaming, devices and search advertising, generated $15.12 billion in revenue, which was up 14% and came in higher than the $13.47 billion FactSet consensus estimate. Technology industry research company Gartner estimated that PC shipments, excluding Chromebooks, grew 10.7% in the quarter.....”

I expect similar growth levels to be reported by D4T4 given the interconnect-ability, capacity, rapid data access and security their platform offers to their extensive blue chip client list. The framework is truly coming into play now giving big data access from home.

Usual caveats

Trek

I posted this on the 10th January.....

“The finals intimated the worse was over. I do think a raise will be needed. They can’t go on waiting for conversions or issuing stock in place of cash.

It’s not a problem raising cash. It’s one of the many reasons to list on AIM to have access to capital. It’s why you raise it and what you do with it that matters. It they announce a big deal and placing at 2.5 then the SP could actually take off on the back of it.

Atm they are working under the spectre of financial constraint.”

The obvious question is if it was oversubscribed then why wasn’t the placing at 2.5p? Clearly they couldn’t drive that price.

I expect this will unfortunately drop to the placing price now as opposed to take off having ticked off the finances. Furthermore, whilst accreditations are essential there is so much detail missing on the ops front.

All is not lost and a great recovery play. Can go back on the watchlist now.

Trek

I looked a EQT a while back. Just a case of a small table cloth and a big table i’m afraid. My preference in the ESG small cap sector is a disruptive graphene play Directa Plus (DCTA). I have held for over 2 years.

Patrick Soon-Shiong, affectionately known has the world’s richest doctor, a multi-billionaire with his own green Co Nant Enterprise bought 28% of DCTA!

They are Ebitda positive and their subsidiary Setcar, have broken into recycling oil from tanks and waste ground recovering over 99% without impurity. This has opened up a potential multi-billion pound industry using Grafysorber.

Grafysorber is also used to recycle tarmac. You don’t go to the quarry. You dig up what’s there add in the mix and re-lay it. The savings are huge in quarry and transport costs and it’s over 200% stronger beats every elasticity measure exceeds all temperature coefficient stress tests compared to standard tarmac. They resurfaced Rome airport, Parts of UK motorway trials (Kent &Oxford) US roads and pedestrian areas in Milan. It has exceeded all tests. Just in time for government Keynesian infrastructure spends!

They put graphene in face masks before RMS, PlanarTech, VRS etc and were first to prove it’s kill rate 99.9% on live covid-19 virus at university of Milan. Oh and they are exceeding sales targets but it’s high end, Formula 1 is a contract. They are now putting it into plastics, think keyboards, phone case, car dashboard and fabrics which is just an add on to their apparel range. Think car seats to your jacket.

Their graphene apparel tech is used by high end sports ‘bob sleigh’ and cycling.

It’s also in tyres now. Increases longevity and reduces rolling resistance so improves economy. They have a contract with a major tyre producer to bring to market.

Probably what will be the most profitable is they have a contract to produce graphene for NexTech a US battery company. It’s with customer trials atm as its extend life of batteries significantly. They smashed all the previous lithium battery targets! Now NexTech have a contract with the US military. Drones, AI robotics, bog standard batteries...

I could go on...They have hundreds of patents. Existing and new ones pending across the world.

I have had several email exchanges with the CEO, Giulio Cesareo, who is absolutely passionate about making the world a better place through disruptive technologies.

£58m mcap, 61m shares in issue. Very illiquid though which is one of the reasons they are held back, the trading patterns spread etc puts folk off and these things take time to scale up.

However, its an example of how DYOR can throw up great companies if you are serious about ignoring the herd and doing you own thing. There has only been a few of us there. One of the posters ‘itsyou’ is along with Zengas (SAVE), Paddy Gal (ggp) is among v best on LSE!

Or if it’s biotech, Oncimmune, (ONC) that can detect common cancers 4 years in advance!

I could go on.

Trek

It’s the way it goes. You don’t always have funds when it’s the best price. I bought at around 12p, 15p, 20p and likewise today at 22.5p. This article led me here having researched all the ‘potential 10 baggers’. Some I was already familiar with and either already held/hold or discounted but having researched further into KMK I actually thought they could do it from a low MCAP and high sales. That was from 12p, so 120p is my target.

“Alternatively, there are companies, such as Kromek Group (LSE:KMK), that have spent millions of pounds developing technology that has yet to be fully exploited. Kromek’s medical imaging, security and nuclear detection technology has already generated significant orders and investment has increased capacity. Contracts have been delayed but Kromek should bounce back and return to growth. ”

https://www.ii.co.uk/analysis-commentary/finding-10-bagger-shares-aim-ii513923

Trek

CB said in the last proactive interview he’d been approached by shenyang. He also said ‘of course the also have warrants’.

In the RNS today Novum was appointed from immediate effect. I am pretty sure they were picked because they made CB confident that they had interested clients on their books. The rns virtually says as much.

He also said no need for additional finance, well we have in effect just had it!

This reminds me of being in VRS when Miton were selling from 13-18p. Once they cleared the SP rocketed as all the good news then came into play once the seller was gone.

Similar here. Shenyang may keep or the broker could take em all. We’ll see but the story remains the same. There just may be a chance to buy some cheaper shares in this window!

Unfortunately I am fully invested now but if I can later I will look to flip some more into here.

And yes I think buy another rig and fit the sheds out!

Usual caveats

Trek